139 related articles for article (PubMed ID: 29374814)
1. Risk of renal stone formation in patients treated with luteinising hormone-releasing hormone analogues for prostate cancer: importance of bone metabolism and urine calcium.
Diaz-Convalia E; Arrabal-Polo MA; Cano-Garcia MDC; Dominguez-Amillo A; Canales-Casco N; Arrabal-Martin M
Int Urol Nephrol; 2018 Mar; 50(3):419-425. PubMed ID: 29374814
[TBL] [Abstract][Full Text] [Related]
2. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.
Arrabal-Polo MA; Girón-Prieto MS; Cano-García Mdel C; Poyatos-Andujar A; Quesada-Charneco M; Abad-Menor F; Arias-Santiago S; Zuluaga-Gomez A; Arrabal-Martin M
Urology; 2015 Apr; 85(4):782-5. PubMed ID: 25817102
[TBL] [Abstract][Full Text] [Related]
3. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
[TBL] [Abstract][Full Text] [Related]
4. [Altered urinary calcium excretion in prostate cancer patients subjected to androgen deprivation. Preliminary pilot study results.].
Díaz-Convalía EJ; Arrabal-Martín M; Arrabal-Polo MÁ; Miján-Ortiz JL; Cózar-Olmo JM
Arch Esp Urol; 2018 Sep; 71(7):569-574. PubMed ID: 30198847
[TBL] [Abstract][Full Text] [Related]
5. Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
Girón-Prieto MS; Arias-Santiago S; Del Carmen Cano-García M; Poyatos-Andújar A; de Haro-Muñoz T; Abad-Menor F; Quesada-Charneco M; Arrabal-Polo MÁ; Arrabal-Martín M
Int Urol Nephrol; 2016 Nov; 48(11):1777-1781. PubMed ID: 27376897
[TBL] [Abstract][Full Text] [Related]
6. Is the fasting calcium/creatinine a bone resorption marker in patients with calcium renal stones?
Arrabal-Polo MA; Arrabal-Martin M; Poyatos-Andujar A; Cardenas-Grande E; Merino-Salas S; Zuluaga-Gomez A
Urol Res; 2012 Jun; 40(3):243-5. PubMed ID: 22138794
[TBL] [Abstract][Full Text] [Related]
7. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
Diamond T; Campbell J; Bryant C; Lynch W
Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
[TBL] [Abstract][Full Text] [Related]
8. Association of severe calcium lithogenic activity and bone remodeling markers.
Arrabal-Polo MÁ; Arrabal-Martín M; Girón-Prieto MS; Orgaz-Molina J; Quesada-Charneco M; López-Ruiz A; Poyatos-Andujar A; Zuluaga-Gómez A; Arias-Santiago S
Urology; 2013 Jul; 82(1):16-21. PubMed ID: 23601442
[TBL] [Abstract][Full Text] [Related]
9. Urinary calcium excretion and bone turnover in osteoporotic patients
.
El-Husseini A; Chakraborty A; Yuan Q; Inayatullah S; Bush H; Sawaya BP
Clin Nephrol; 2017 Nov; 88(11):239-247. PubMed ID: 29017699
[TBL] [Abstract][Full Text] [Related]
10. Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide.
Arrabal-Martín M; González-Torres S; Cano-García MD; De Haro-Muñoz T; Abad-Menor F; Arrabal-Polo MÁ; Cózar-Olmo JM
Urol Int; 2016; 97(3):292-298. PubMed ID: 26800461
[TBL] [Abstract][Full Text] [Related]
11. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS
J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
[TBL] [Abstract][Full Text] [Related]
12. The value of hypercalciuria in patients with osteopenia versus osteoporosis.
Girón-Prieto MS; Del Carmen Cano-García M; Poyatos-Andújar A; Arias-Santiago S; de Haro-Muñoz T; Arrabal-Martín M; Arrabal-Polo MÁ
Urolithiasis; 2017 Jun; 45(3):279-283. PubMed ID: 27480097
[TBL] [Abstract][Full Text] [Related]
13. [The fasting calcium/creatinine ratio in patients with calcium stones and the relation with hypercalciuria and phosphocalcium metabolism].
Arrabal-Polo MÁ; del Carmen Cano-García M; Arrabal-Martín M
Arch Esp Urol; 2016 Apr; 69(3):117-20. PubMed ID: 27068369
[TBL] [Abstract][Full Text] [Related]
14. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; Poyatos-Andujar A; Zuluaga-Gomez A
BJU Int; 2013 Apr; 111(4):622-7. PubMed ID: 22757744
[TBL] [Abstract][Full Text] [Related]
15. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma.
Schmiedl A; Schwille PO
Magnes Res; 2003 Sep; 16(3):192-205. PubMed ID: 14596324
[TBL] [Abstract][Full Text] [Related]
16. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
Wadhwa VK; Weston R; Mistry R; Parr NJ
BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy in prostate cancer and risk of developing renal calculi: Results of a case-control study.
Díaz Convalía EJ; Cano-García MDC; Miján-Ortiz JL; Arrabal-Martín M; Arrabal-Polo MÁ; Cózar-Olmo JM
Med Clin (Barc); 2017 Jun; 148(11):495-497. PubMed ID: 28256207
[TBL] [Abstract][Full Text] [Related]
19. A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study.
Klotz LH; McNeill IY; Kebabdjian M; Zhang L; Chin JL;
Eur Urol; 2013 May; 63(5):927-35. PubMed ID: 23040208
[TBL] [Abstract][Full Text] [Related]
20. Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass.
Park SM; Joung JY; Cho YY; Sohn SY; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK
Eur J Clin Nutr; 2015 Mar; 69(3):361-6. PubMed ID: 25649239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
